+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Kanamycin"

Aminoglycosides Global Market Report 2024 - Product Thumbnail Image

Aminoglycosides Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Kanamycin is an antibiotic used to treat a variety of bacterial infections. It belongs to the aminoglycoside class of antibiotics, which are used to treat serious infections caused by Gram-negative bacteria. Kanamycin is effective against a wide range of bacteria, including those that cause tuberculosis, meningitis, and sepsis. It is also used to treat infections caused by Mycobacterium avium complex (MAC). Kanamycin is available in both oral and injectable forms. Kanamycin is used in combination with other antibiotics to treat serious infections. It is often used in combination with other antibiotics to treat infections caused by resistant bacteria. It is also used to treat infections caused by Pseudomonas aeruginosa, a type of bacteria that is resistant to many other antibiotics. Kanamycin is widely used in the treatment of bacterial infections. It is available in many countries and is used in both hospital and outpatient settings. It is also used in veterinary medicine to treat bacterial infections in animals. Some companies in the Kanamycin market include Pfizer, Merck, Sanofi, and Novartis. Show Less Read more